¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"metabolic disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® Raynaud disease ÇÑ±Û ·¹À̳뺴
¼³¸í   
  ±â´ÉÀû Ç÷°ü °æ·ÃÀ» ÀÏÀ¸Å°´Â º´À¸·Î °Ç°­ÇÑ ÀþÀº ¿©¼ºÀÇ ÆÈ´Ù¸® ÀÛÀº µ¿¸ÆÀ» Ä§¹üÇÑ´Ù. ÇÁ¶û½º ÀÇ»ç M.·¹À̳ë(1834~1881)°¡ º¸°íÇÑ °ÍÀ¸·Î ÀÌ º´Àº ÁַΠ¼Õ°¡¶ô, ¼Õ, ¶§·Î´Â ÄÚ³¡À̳ª ¹ßµî, ¸öÀÇ ¸»´ÜºÎ ¼Òµ¿¸ÆÀ» Ä§¹üÇÑ´Ù. Çѳðú °¨Á¤Àڱؿ¡ ÀÇÇϸ砼հ¡¶ôÀº ¹é»öÀ¸·Î ´ÙÀ½Àº Ã»»öÀ¸·Î, ±×¸®°í Àû»öÀ¸·Î º¯ÇÑ´Ù. ¿©¼º¿¡°Ô È£¹ßÇÑ´Ù.
¿µ¹® rheumatic heart disease ÇÑ±Û ·ù¸¶Æ¼½º½ÉÀ庴
¼³¸í   
  »ç½½¾Ë±Õ°¨¿° ÈÄ »ý±â´Â ½ÉÀåÆÇ¸·º´ÀÌ´Ù. ¿øÀÎÀº A±º -¿ëÇ÷»ç½½¾Ë¿¡ ÀÇÇÑ Àεο°ÈÄ ÀÏÁ¾ÀÇ ¸é¿ª¹ÝÀÀÀ¸·Î ¹ßº´ÇÑ´Ù.
  
  Áø´ÜÀº Á¸ÀÇ ±âÁØ¿¡ ÀÇÇÑ´Ù.
  
  (1) ÁÖ¿ä±âÁØÀº °üÀý¿° ½ÉÀå¿°(½ÉÀåºñ´ë, ½ÉÀåÀâÀ½, ½ÉÀå±â´É»ó½Ç µî) ¹«µµÁõ: ¹«´çÀÌ ÃãÀ» Ãߴ °Í °°Àº ÇൿÀÇ ¹ßÀÛÁõ¼¼. ¿¬º¯È«¹Ý: »¡°£ Å׵θ®¸¦ °¡Áø ÇǺκ´º¯Àº ÇÇÇϰáÀý(subcutaneous nodule): ÇǺΠ¹Ø¿¡ »ý±ä °áÀý,
  
  (2)Âü°í ±âÁØÀº ¿­, °üÀýÅë, EKG»ó PR¿¬Àå: ½ÉÀüµµ ¼Ò°ß ±Þ¼º±â ¹ÝÀÀ¹°Áú(¿¹: ESR, CRP)ÀÇ »ó½Â, ·ù¸¶Æ¼½º¿­
  
  Ä¡·á´Â Æä´Ï½Ç¸°À¸·Î Ä¡·áÇÏ°í ½ÉÀåÀÇ ÈÄÀ¯Áõ ¶ÇÇÑ Æä´Ï½Ç¸°À¸·Î ¿¹¹æÇÑ´Ù.
¿µ¹® chronic obstructive pulmonary disease ÇÑ±Û ¸¸¼ºÆó¼âÆóº´
¼³¸í   
  ¸¸¼ºÀûÀ¸·Î ±âµµÀÇ Æó¼â¸¦ °¡Á®¿À´Â º´À» À̸£´Â ¸». ´ë°³ ¸¸¼º±â°üÁö¿°, ±â°üÁö Ãµ½Ä, Æó±âÁ¾ÀÇ 3°¡Áö º´À» ¸»ÇÑ´Ù.
  
  ¸¸¼º±â°üÁö¿°À̶õ ±â°üÁöÀÇ ¸¸¼º¿°ÁõÀ» ¸»ÇÑ´Ù. ±â°üÁöÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ¼­ ±â°üÁöÀÇ Á¡¸·¿¡ ºÎÁ¾ÀÌ »ý±â°í À̷ΠÀÎÇØ¼­ ±â°üÁöÀÇ ³»°æÀÌ Á¼¾ÆÁ®¼­ ±âµµÀÇ Æó¼â¸¦ °¡Á®¿Â´Ù. ´ë°³ Èí¿¬°ú ¹ÐÁ¢ÇÑ ¿¬°üÀ» °¡Áö¸ç, È£Èí°ï¶õ, ±âħ, ±×¸®°í °¡·¡(´ë°³ »öÀ̠Ǫ¸£°í Á¡µµ°¡ ³ôÀº °¡·¡)°¡ Áõ»óÀ¸·Î ³ªÅ¸³­´Ù.
  
  Æó±âÁ¾Àº ±â°üÁöÀÇ º®À» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ ±â°üÁö°¡ Á¦ ¸ð¾çÀ» °®ÃßÁö ¸øÇÏ°í ¹«³ÊÁö°Ô µÇ¾î ±âµµÀÇ Æó¼â°¡ ÀϾ´Â º´ÀÌ´Ù. Áï ±â°üÁö°¡ °ü ¸ð¾çÀ¸·Î ÆØÆØÇϰԠÆìÁö´Â °ÍÀ» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ °ü¸ð¾çÀ¸·Î ÆìÁöÁö ¸øÇØ °á±¹Àº ÆóÆ÷³»¿¡ °ø±â°¡ Â÷°í ÆóÆ÷º®ÀÌ ÆÄ¿­µÇ°í ±â°üÁö°¡ Á¼¾ÆÁö°Ô µÇ´Â º´À» ¸»ÇÑ´Ù.
  
  ±â°üÁöõ½ÄÀ̶õ ¿©·¯ °¡Áö Àڱؿ¡ ´ëÇØ¼­ ±â°üÁö°¡ °ú¹ÎÇÑ ¹ÝÀÀÀ» º¸¿©¼­ »ý±â´Â ±â°üÁöÀÇ °¡¿ªÀûÀΠÆó¼â¸¦ ÀǹÌÇÑ´Ù. Áï Á¤»óÀο¡°Ô¼­´Â ±â°üÁöÀÇ Æó¼â¸¦ º¸ÀÌÁö ¾Ê´Â Àڱؿ¡ ´ëÇØ¼­ ±â°üÁöÀÇ Æó¼â°¡ »ý±â°í ±× ÀÚ±ØÀÌ ¾øÀ» °æ¿ì¿¡´Â ±â°üÁöÀÇ Æó¼â°¡ ¾ø¾îÁö´Â º´À» ¸»ÇÑ´Ù. 
¿µ¹® Buerger disease ÇÑ±Û ¹ö°Åº´
¼³¸í   
  ¸»ÃÊ µ¿¸Æ°ú Á¤¸Æ¿¡ ¿°ÁõÀ» ÀÏÀ¸Å°´Â º´. Ã»Àå³âÃþÀÇ ³²ÀÚ¿¡°Ô Àß °É¸®´Â ´Ù¸® µ¿¸Æ¿¡ »ý±â´Â º´À¸·Î µ¿¸ÆÀÌ ¸·È÷°í ÅëÁõ ¶§¹®¿¡ ¹ßÀ» Àý±âµµ Çϴµ¥ ¿øÀÎÀº ¾Ë·ÁÁ® ÀÖÁö ¾Ê´Ù. º´¸íÀº ÀÌ º´À» ÃÖÃʷΠ»ó¼¼ÇϰԠº¸°íÇÑ ¹Ì±¹ÀÇ ÀÇ»ç L. ¹ö°Å(1879~1943)ÀÇ À̸§¿¡¼­ ¿¬À¯ÇÑ´Ù. µ¿¾çÀο¡°Ô ¸¹Àº º´À¸·Î, ´ëºÎºÐ ÀþÀº ³²¼º, Æ¯È÷ Àå³â±â ³²¼º¿¡°Ô¼­ ³ªÅ¸³­´Ù. ¿øÀÎÀº ¾Ë ¼ö ¾øÀ¸³ª Èí¿¬ÀÌ º´ÀÇ ¾ÇÈ­¸¦ ÃÊ·¡ÇÑ´Ù. »çÁöÀÇ µ¿¸Æ°ú Á¤¸Æ¿¡ ¿°ÁõÀÌ ÀϾ Ç÷ÀüÀÌ »ý±â¸é ³»°­À» ¸·¾Æ Ç÷¾×ÀÌ È帣Áö ¸øÇϰԠµÇ¾î ±× ¾ÕÀÇ ¸»ÃÊÁ¶Á÷ÀÌ ±«»ç¿¡ ºüÁö°Å³ª ¼Õ¹ßÀÌ Â÷°©°í, ¼Õ°¡¶ô-¹ß°¡¶ôÀÌ º¸¶ó»ö ¶Ç´Â °ËÀº»öÀ¸·Î º¯ÇÑ´Ù. ¶Ç, ÀÌ Áõ¼¼°¡ °è¼ÓµÇ´Â µ¿¾È ¼Õ¹ß°¡¶ô¿¡ ÅëÁõÀÌ ÀϾ°í ±Ë¾çÀÌ ¹ß»ýÇÑ´Ù. Ä¡·á´Â Áõ¼¼ÀÇ Á¤µµ¿Í Æó»öµÈ Ç÷°üÀÇ ºÎÀ§¿¡ µû¶ó ¿¬°í¸¦ ¹Ù¸£°Å³ª Ç÷°üÈ®ÀåÁ¦-¼øÈ¯°³¼±Á¦-Ç÷¼ÒÆÇÀÀÁý¾ïÁ¦Á¦¸¦ »ç¿ëÇϳª, ¾î¶² Ä¡·áµµ È¿°ú°¡ ¾øÀ» °æ¿ì ¼Õ¹ß°¡¶ôÀÇ ¼ÒÀý´Ü, µå¹°°Ô´Â ¹«¸­ ÀÌÇÏÀÇ ´ëÀý´ÜÀ» ÇؾߠÇÑ´Ù. ÀϹÝÀûÀ¸·Î ÀÌ º´ÀÇ ¿¹ÈĴ ¾çÈ£ÇÏ¿© Ç÷·ù°¡ È¸º¹µÇ°í ±Ë¾ç¸¸ Ä¡·áµÇ¸é Àç¹ßÀÌ Àû´Ù.
¿µ¹® Behcet disease ÇÑ±Û º£Ã¼Æ®º´
¼³¸í   
  ½ÉÇÑ Æ÷µµ¸·¿°, ¸Á¸·Ç÷°ü¿°, ½Ã°¢½Å°æÀ§Ãà, ±¸°­-¼º±âÀÇ ¾ÆÇÁŸ¼º ±Ë¾ç, ±¤¹üÀ§ÇÑ Ç÷°ü¿°ÀǠ¡ÈĿ͠Áõ»óÀ» ³ªÅ¸³½´Ù. ¿øÀκҸíÀÇ Èñ±ÍÇÑ º´À¸·Î ÀþÀº ³²ÀÚ¿¡°Ô Àß ¹ß»ýÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • metabolic error
    ´ë»çÀÌ»ó
  • metabolic imbalance
    ´ë»çºÒ±ÕÇü
  • metabolic inhibitor
    ´ë»ç¾ïÁ¦Á¦
  • metabolic map
    ´ë»ç°æ·Îµµ
  • metabolic monitoring
    ´ë»ç·®Á¶»ç
  • metabolic network
    ´ë»ç¸Á, ´ë»ç±×¹°
  • metabolic pathway
    ´ë»ç°æ·Î
  • metabolic rate
    ´ë»çÀ²
  • metabolic regulation
    ´ë»çÁ¶Àý
  • metabolic water
    ´ë»ç¼ö
  • relative metabolic rate
    »ó´ë´ë»çÀ²
  • somnolent metabolic rate
    ¼ö¸é´ë»çÀ²
  • anti-GBM disease
    Ç×GBMº´
  • arteriosclerotic cardiovascular disease
    µ¿¸Æ°æÈ­½É(Àå)Ç÷°üº´
  • arteriosclerotic heart disease
    µ¿¸Æ°æÈ­½ÉÀ庴
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Cushing's disease
    Äí½Ìº´
  • de Quervain's disease
    µåÄõº£Àκ´
  • degenerative disease
    ÅðÇິ
  • fibrocystic disease
    ¼¶À¯³¶º´
  • glomerular disease
    Å丮º´, »ç±¸Ã¼Áúȯ
  • Hashimoto's disease
    ÇϽøðÅ亴
  • Hirschsprung's disease
    (¢¡ congenital megacolon) È÷¸£½´½´ÇÁ·îº´
  • hyaline membrane disease
    À¯¸®Áú¸·º´
  • infectious disease
    °¨¿°º´
  • inflammatory bowel disease
    ¿°ÁõâÀÚÁúȯ
  • inherited disease
    À¯Àüº´
  • Legg-Calve-Perthes disease
    (¢¡ostetochondrosis of the capitualar epiphysis of th) ·¹±×Ä®º£Æä¸£Å×½ºº´, ³Ò´Ù¸®»À¸Ó¸®»À³¡»À¿¬°ñÁõ
  • life style disease
    »ýȰ½À°üº´
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • moyamoya disease
    ¸ð¾ß¸ð¾ßº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • metabolic hypothesis
    ´ë»ç°¡¼³
  • metabolic imbalance
    ´ë»çºÒ±ÕÇü
  • metabolic inhibitor
    ´ë»ç¾ïÁ¦Á¦
  • metabolic
    ´ë»ç-
  • metabolic map
    ´ë»ç°æ·Îµµ
  • metabolic monitoring
    ´ë»ç·®Á¶»ç
  • metabolic network
    ´ë»ç¸Á
  • metabolic pathway
    ´ë»ç°æ·Î
  • metabolic rate
    ´ë»çÀ²
  • metabolic regulation
    ´ë»çÁ¶Àý
  • metabolic tolerance
    ´ë»ç³»¼º
  • metabolic turnover
    ´ë»çÀüȯ
  • metabolic water
    ´ë»ç¼ö
  • relative metabolic rate
    »ó´ë´ë»çÀ²
  • somnolent metabolic rate
    ¼ö¸é´ë»çÀ²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Balos disease
    ¹ß·Îº´.
  • Bantis disease
    ¹ÝƼº´ ¡ì°£Á¾Ã¢¼º ºñÁ¾¡í.
  • Beards disease
    º£¾îµåº´=¼è¾àÁõÈıº(neurasthenia)
  • Beh ets disease
    º£Ã¼Æ®º´
  • Behcets disease
    º£¼¼Æ®º´
  • Behrs disease
    º£¸£º´
  • Bernard-Soulier disease
    º£¸£³ª¸£-¼ú¸®¿¡Áúȯ<--º´> ?
  • Bournevilles disease->tuberous sclerosis
    ºÎ¸£³×ºôº´
  • Bowens disease
    º¸À¢ º´
  • Brill-Zinsser disease
    ºê¸±-Áø¼­ Áúȯ
  • Brill-Zinsser disease
    ºê¸±-Áø¼­º´
  • Buergers disease
    ¹ö°Åº´.
  • Burgers disease
    ¹ö°Åº´.
  • COPD=> chronic obstructive pulmonary disease
    ¸¸¼ºÆó»ö(¼â)¼º ÆóÁúȯ(Ø·àõøÍßáàõøËòðü´)
  • Carrions disease
    Ä«¸®¿Âº´.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • metabolic alkalosis
    ´ë»ç¼º ¾ËÄ®¸®Áõ.
  • metabolic alkalosis
    ´ë»ç¼º ¿°±âÁõ
  • metabolic alkalosis
    ´ë»ç¼º¾ËÄ«¸®Áõ
  • metabolic analogue
    ´ë»çÀû À¯»ç¹°Áú.
  • metabolic antagonism
    ´ë»ç±æÇ×(¡­ÑÏù÷).
  • metabolic antagonist
    ´ë»ç±æÇ×Á¦(¡­ÑÏù÷ð¥).
  • metabolic chemistry
    ´ë»çÈ­ÇÐ.
  • metabolic clearance rate =MCR
    ´ë»çŬ¸®¾î·±½ºÀ².
  • metabolic clock
    ´ë»çÀÛ¿ëÀÇ ½Ã°£Àû ¸®µë.
  • metabolic craniopathy
    ´ë»ç¼º µÎ°³Àå¾Ö(¡­ÔéËÏî¡äô).
  • metabolic cycle
    ´ë»çÁÖ±â.
  • metabolic defect of amino acid (alkaptonuria)
    ¾Æ¹Ì³ë»ê´ë»ç°áÇÔ(¾Ëİſ´¢Áõ)
  • metabolic defect of carbohydrate (galactosemia)
    ź¼öÈ­¹°´ë»ç°áÇÔ(°¥¶ôÅä¿À½ºÇ÷?
  • metabolic defect of minerals (asiderosis)
    ¹«±âÁú´ë»ç°áÇÔ(ö°¨¼ÒÁõ)
  • metabolic defect of nucleic acid (purinemia)
    ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • metabolic poison
    ´ë»ç µ¶(ÓÛÞóÔ¸)
  • metabolic pool
    ´ë»ç(ÓÛÞó) Ç®
  • metabolic quotient
    ´ë»ç»ó(ÓÛÞóßÂ)
  • metabolic shunt
    ´ë»ç ºÐ·Î(ÓÛÞóÝÂÖØ)
  • metabolic transformation
    ´ë»ç º¯Çü(ÓÛÞóܨû¡)
  • metabolic turnover
    ´ë»ç ÀüÈ­(ÓÛÞóï®ûù)
  • reversible metabolic pathway
    °¡¿ª ´ë»ç°æ·Î(ÓÛÞóÌèÖØ)
  • tiered metabolic pathway
    ÃþÃþ´ë»ç °æ·Î (öµöµÓÛÞóÌèÖØ)
  • Addison's disease
    ¿¡µð¼Õ º´(Ü»)
  • alkali disease
    ¾ËÄ®¸®¼ºÁúȯ(òðü´)
  • allogeneic disease
    µ¿Á¾ÀÌÀÎÀÚÇü Áúȯ(ÔÒðúì¶ì×í­úþ òðü´)
  • Alzheimer disease
    ¾ËÁîÇÏÀÌ¸Ó º´(Ü»)
  • Andersen's disease
    ¾Èµ¥¸£¼¾º´(Ü»)
  • autoallergic disease
    ÀÚ°¡(í»Ê«)¾Ë·¹¸£±â Áúȯ(òðü´)
  • autoimmune disease
    ÀÚ°¡¸é¿ªÁúȯ (í»Ê«Øóæ¹òðü´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • constitutional disease
    üÁú¼ºÁúȯ
  • coronary heart disease
    °ü»óµ¿¸Æ½ÉÁúȯ
  • Crohn's disease
    Å©·Ðº´
  • Crouzon's disease
    µÎ°³¾È¸éȸ°ñºÎÀüÁõ, Å©·çÁ¸º´
  • cyanotic heart disease
    û»ö¼º½ÉÀåÁúȯ
  • degenerative joint disease
    ÅðÇ༺°üÀýÁúȯ
  • demyelinating disease
    Å»¼öÃʼºÁúȯ
  • disease
    º´, Áúº´, Áúȯ
  • endemic disease
    Áö¹æº´, dzÅ亴
  • endocrine disease
    ³»ºÐºñÁúȯ
  • focal disease
    ÃÊÁ¡¼ºÁúȯ
  • glycogen storage disease
    ±Û¸®ÄÚ°Õ ÃàÀûÁúȯ
  • granulomatous disease
    À°¾ÆÁ¾¼ºÁúȯ
  • Hand-Schueller-Christian disease
    ÇÚµå-½¯·¯-Å©¸®½ºÂùº´
  • Hashimoto's disease
    ÇϽøðÅ亴
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RD radial deviation; radiology department; rate difference; Raynaud disease; reaction of degeneration; ...
CHD Chediak-Higashi disease; childhood disease; chronic hemodialysis; congenital or congestive heart dis...
CRD carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
AHD acquired hepatocerebral degeneration; acute heart disease; antihyaluronidase; antihypertensive drug;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CMRO2 Cerebral metabolic rate of oxygen
CMA Chronic metabolic acidosis
FMR Field metabolic rate
LCMRglc Local cerebral metabolic rate for glucose
MCR Metabolic Clearance Rate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • kufs's disease °¡Á·¼º Èæ³»À强 ¹éÄ¡ÀÇ ¸¸¹ß¼º ¿¬¼ÒÇüÀÌ´Ù.

    Kugelberg-Welander disease ±Ù À§ÃàÁõÀÇ À¯Àü¼º ¿¬¼ÒÇüÀ¸·Î¼­ º¸Åë »ó¿°»öü¼º ¿­¼º ÇüÁú·Î À¯ÀüµÈ´Ù. ô¼ö Àü°¢ÀÇ º´º¯ÀÌ ±× ¿øÀÎÀÌ´Ù.

    kukuruku ¿øÀÎ ºÒ¸íÀ̸ç, ³ªÀÌÁö¸®¾Æ¿¡¼­ º¼ ¼ö ÀÖ´Â ÁúȯÀ¸·Î, ¿­

    °£Àå ´ë½Ä ¼¼Æ÷
  • Acosta's disease
    ¾ÆÄÚ½ºÅ¸º´
    µ¿ÀǾî=acute mountain sickness.
  • acquired cystic disease
    ÈÄõ¼º ³¶¼º Áúȯ
  • acquired heart disease
    ÈÄõ¼º ½É Áúȯ
    »ýÈÄ¿¡ ¾ò¾îÁø ½ÉÀå Áúȯ.
  • acute demyelinating disease
    ±Þ¼º Å»¼öÃʼº Áúȯ
  • acute infectious disease
    ±Þ¼º Àü¿°º´
    ¹ßº´ ÈÄ ¼öÀÏ- ¼öÁÖÀÏ·Î Ä¡À¯ ¶Ç´Â »ç¸ÁÇÏ´Â Àü¿°º´. ¾ö¹ÐÇÏ°Ô ±Þ¼º°ú ¸¸¼ºÀ» ±¸º°ÇÒ ¼ö ¾ø´Âµ¥, ÀϹÝÀûÀ¸·Î ¿¬±¸, ´ëÃ¥ÀÇ ÆíÀÇ»ó ºÐ·ùµÈ´Ù. ±Þ¼º Àü¿°º´Àº Áßµ¶ÀÏ °æ¿ì »ç¶÷µéÀÇ ÁÖ¸ñÀ» ¹Þ±â ½±°í, ¿¬±¸, ´ëÃ¥µµ ½Ç½ÃÇϱ⠽±´Ù. ÄÝ·¹¶ó, Æä½ºÆ®, µÎâ, Æú¸®¿À µîÀÌ ±×°ÍÀÌ´Ù. ÇÑÆí °æÁõÀÎ °ÍÀº ±×´ÙÁö Áß¿ä½Ã µÇÁö ¾Ê±â ¶§¹®¿¡ ¿¬±¸, ´ëÃ¥µµ ´Ê¾îÁö°í ÀÖ´Â °ÍÀÌ ¸¹´Ù. ÀÎÇ÷翣ÀÚ, È«¿ª, ¼öµÎ µîÀÌ ±× ¿¹ÀÌ´Ù.
  • adipose tissue disease
    Áö¹æ Á¶Á÷ Áúȯ
  • adrenal cortex disease
    ºÎ½Å ÇÇÁú Áúȯ
    ºÎ½Å ÇÇÁúÀÇ ±â´ÉÀå¾Ö·Î ÀÎÇØ »ý±ä º´. ±â´É ÀúÇÏ·Î ÀÎÇØ¼­´Â ¿¡µð½¼¾¾ º´
  • adult celiac disease
    ¼ºÀÎÇü ¼¿¸®¾ÆÅ©
    Áö¹æº¯ÁõÀÇ ¼ºÀκ´ ¶Ç´Â ºñ¿­´ë¼º ½ºÇÁ·ç¿ì.
  • African sleeping disease
    ¾ÆÇÁ¸®Ä« ¼ö¸éº´
  • air space disease
    °ø°£ Áúȯ
  • Akureyri disease
    ¾ÆÄí·¹À̸®º´
    ¾ç¼º ±ÙÅë ³úô¼ö¿°. ºÏ¾ÆÀ̽½¶õµå ¸¶À»ÀÇ À̸§À» µý °ÍÀÌ´Ù.
  • albers-schonberg disease
    º£¸£½º-½¨º£¸£Å©º´
  • allergic disease
    ¾Ë·¹¸£±â¼º Áúȯ
    1. ¾Ë·¹¸£±â´Â ¸é¿ª ¹ÝÀÀÀÇ º´Àû °úÁ¤À¸·Î¼­ ±× Á¤Àǰ¡ ³»·ÁÁ® ÀÖ°í, ¹ßº´ ±âÀü¿¡¼­ ¥°Çü, ¥±Çü, ¥²Çü ¹× ¥³ÇüÀ¸·Î ºÐ·ùµÇ¾î ÀÖ´Ù. ¥°ÇüÀº IgE classÀÇ Ç×ü, ¥±ÇüÀº IgG ¹× IgM classÀÇ Ç×ü, ¥²ÇüÀº ¸é¿ªº¹ÇÕü, ¥³ÇüÀº °¨ÀÛ¸²ÇÁ±¸°¡ °¢°¢ ƯÀÌÀûÀÎ ¸é¿ª¹ÝÀÀ ÀÎÀÚÀÌ´Ù. ÀÌ º´Àû °úÁ¤ÀÇ °á°ú·Î ¹ß»ýÇÏ´Â ÁúȯÀ» ¾Ë·¹¸£±â¼º ÁúȯÀ̶ó°í ºÎ¸¥´Ù. ¥°Çü ¾Ë·¹¸£±â Áúȯ¿¡´Â ±â°üÁö õ½Ä, µÎµå·¯±â, ¾Ë·¹¸£±â¼º ºñ¿°°ú °ïÃæ ¾Ë·¹¸£±â, ¥±Çü ¾Ë·¹¸£±â¿¡´Â Ç÷¾×Çü ºÎÀûÇÕ ¿ëÇ÷¼º ºóÇ÷, ¾Ë·¹¸£±â¼º Ç÷¼ÒÆÇ ¹éÇ÷±¸ °¨¼ÒÁõ µî, ¥²Çü ¾Ë·¹¸£±â¿¡´Â Ç÷ûº´, ³óºÎÁõ°ú »ç±¸Ã¼ ½Å¿° µî, ¥³Çü ¾Ë·¹¸£±â¿¡´Â øÃ˼º ÇǺο°, °áÇÙÀ» µé ¼ö ÀÖ´Ù. ±âŸ ¾î¶² ÇüÀÇ ¾Ë·¹¸£±â°¡ °ü¿©Çϰí ÀÖ´ÂÁö ºÐ¸íÈ÷ ±¸º°Àº ÇÒ ¼ö ¾øÁö¸¸ °¢Á¾ ±³¿øº´À̳ª ÀÚ°¡¸é¿ª Áúȯµµ ¾Ë·¹¸£±â¼º ÁúȯÀÇ ¹üÁÖ¿¡ µé¾î°£´Ù. 2. ¾Ë·¹¸£±â¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î »ý°¢µÇ´Â º´ÀÇ ÃÑĪ. Ç÷ûº´, ²É°¡·çº´, ¾Ë·¹¸£±â¼º ºñ¿°, µÎµå·¯±â, ¾à¹° ¾Ë·¹¸£±â, ½ÀÁø µîÀÌ ÀÌ¿¡ ¼ÓÇÏ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù.
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
metabolic equivalent The oxygen cost of energy expenditure measured at supine rest (1 MET = 3.5 ml O2 per kg of body weight per minute); multiples of MET are used to estimate the oxygen cost of activity, e.g., 3 to 5 METs for light work; more than 9 METs for heavy work.
(05 Mar 2000)
metabolic indican 1. <chemistry> A glucoside obtained from woad (indigo plant) and other plants, as a yellow or light brown sirup. It has a nauseous bitter taste, a decomposes or drying. By the action of acids, ferments, etc, it breaks down into sugar and indigo. It is the source of natural indigo.
2. <physiology> An indigo-forming substance, found in urine, and other animal fluids, and convertible into red and blue indigo (urrhodin and uroglaucin). Chemically, it is indoxyl sulphate of potash, C8H6NSO4K, and is derived from the indol formed in the alimentary canal.
Synonym: uroxanthin.
See: Indigo.
Source: Websters Dictionary
(01 Mar 1998)
metabolic mucinosis Diffuse or pretibial myxoedema, lichen myxoedematosus, gargoylism, secondary mucinosis, degeneration in tumours, localised mucinosis, follicular, papular, plaque-like, focal, and myxoid or synovial cyst.
Origin: mucin + G. -osis, condition
(05 Mar 2000)
metabolic pool The quantity of a given chemical compound or group of related compounds participating in metabolic reactions; may constitute only a portion of the total bodily content of such compounds.
(05 Mar 2000)
compensated metabolic alkalosis The retention of acid, primarily carbon dioxide by the lung and acid ions by the renal tubules, to reduce the effect on the pH of the blood of excess alkali produced by ingestion or metabolism of alkali-producing substances.
(05 Mar 2000)
skin diseases, metabolic Diseases of the skin associated with underlying metabolic disorders.
(12 Dec 1998)
steroid metabolic clearance rate A measure of the rate of metabolism of a given steroid within the body, usually expressed as liters of body fluid that contain the amount of steroid metabolised per day.
(05 Mar 2000)
nutritional and metabolic diseases A collective term for nutritional disorders (result of poor assimilation or utilization of food) and metabolic disorders (result of poor metabolism or inherited enzyme abnormality).
(12 Dec 1998)
aaa disease Endemic anaemia of ancient Egypt, ascribed in the Papyrus Ebers to intestinal infestation with ancylostoma; now called ancylostomiasis.
(05 Mar 2000)
ABO haemolytic disease of the newborn Erythroblastosis foetalis due to maternal-foetal incompatibility with respect to an antigen of the ABO blood group; the foetus possesses A or B antigen which is lacking in the mother, and the mother produces immune antibody which causes haemolysis of foetal erythrocytes.
(05 Mar 2000)
accumulation disease A disease characterised by abnormal accumulation of a metabolic product in certain cells and tissues; examples include the mucopolysaccharidoses, lipoidoses.
(05 Mar 2000)
Acosta's disease A condition that results from prolonged exposure to high altitude.
Symptoms include a continuous dry cough, shortness of breath, poor exercise tolerance, dizziness, headache, sleep difficulty, anorexia, confusion, fatigue and a rapid pulse.
Treatment includes the immediate movement to a lower altitude. Prophylaxis has been accomplished successfully with the use of acetazolamide (Diamox).
(27 Sep 1997)
acquired immunodeficiency disease Acquired immunodeficiency disease: Disease caused by infection with the human immunodeficiency virus (HIV).
(12 Dec 1998)
acute disease Disease having a short and relatively severe course.
(12 Dec 1998)
Adams-Stokes disease <syndrome> Transient asystole or ventricular fibrillation in the presence of atrioventricular block.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Riggs' disease
    Ä¡Á¶ ³ó·ç
  • atomic disease
    ¿øÀÚº´
  • atonic disease
    ¿øÀÚº´
  • basedows disease
    ¹ÙÁ¦µµ º´
  • caisson disease
    ÄÉÀ̽¼º´;ÀáÇÔº´
  • celiac disease
    ¼Ò¾ÆÁö¹æº¯Áõ
  • deficiency disease
    ¿µ¾ß ½ÇÁ¶;ºñŸ¹Î °áÇÌÁõ
  • disease
    º´
  • disease germ
    º´¿ø±Õ
  • duck's disease
    (ÀÍ»ì)ªÀº ´Ù¸®
  • fishskin disease
    ¾î¸°¼±
  • footandmouth disease
    ¾Æ±¸Ã¢(°¡ÃàÀÇ ÀÔÀ̳ª ¹ß±Á¿¡ »ý±â´Â Àü¿°º´)
  • footinmouth disease
    ½Ç¾ðº®
  • green monkey disease
    =MARBURG DISEASE
  • heart disease
    ½ÉÀ庴
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á